Risto Roine

Vorapaxar in the secondary prevention of atherothrombotic events (2012)

New England Journal of Medicine

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A subgroup analysis of the ROCKET AF trial (2012)

Lancet Neurology

Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener H-C, Donnan GA, Halperin JL, Mahaffey KW, Mas J-L, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KAA

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Trends in treatment and outcome of stroke patients in Finland from 1999 to 2007. PERFECT Stroke, a nationwide register study (2011)

Annals of Medicine

Meretoja A, Kaste M, Roine RO, Juntunen M, Linna M, Hillbom M, Marttila R, Erilä T, Rissanen A, Sivenius J, Häkkinen U

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Direct costs of stroke patients can be continuously monitored on a national level. PERFECT Stroke database in Finland. (2011)

Stroke

Meretoja A, Kaste M, Roine RO, Juntunen M, Linna M, Hillbom M, Marttila R, Erilä T, Rissanen A, Sivenius J, Häkkinen U

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial (2011)

Lancet

Marie-Germaine Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, de Cordoüe A, Fratacci M-D

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (2011)

New England Journal of Medicine

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, Rocket AF Investigators, (Incl. Roine RO)

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Association of Early National Institutes of Health Stroke Scale Improvement with Vessel Recanalization and Functional outcome After intravenous thrombolysis in ischaemic stroke (2011)

Stroke

Kharitonova T, Mikulik R, Roine R, Soinne L, Ahmed N, Wahlgren N

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Angiotensin receptor blockers for acute stroke: Results of the Scandinavian Candesartan Acute Stroke Trial (SCAST), a randomized, and placebo-controlled trial (2011)

Lancet

Sandset EC, Bath PMW, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thjis V, Berge E

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR (2010)

Lancet Neurology

Ahmed N, Wahlgren N, Grond M, Hennerici M, Lees K R, Mikulik R, Parsons M, Roine R O, Toni D, Ringleb P, for the SITS investigators

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Angiotensin receptor blockade in acute stroke.The Scandinavian Candesartan Acute Stroke Trial. Rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003) (2010)

International Journal of Stroke

Sandset E, Gordon M, Boysen G, Jatuzis D, Kõrv J, Lüders S, Richter P, Roine R O, Terent A, Thijs V, Berge E on behalf of the Scandinavian Candesartan Acute Stroke Trial (SCAST)

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Links

Areas of expertise

Biography

Research

Publications

Sort by:

Vorapaxar in the secondary prevention of atherothrombotic events (2012)

A subgroup analysis of the ROCKET AF trial (2012)

Trends in treatment and outcome of stroke patients in Finland from 1999 to 2007. PERFECT Stroke, a nationwide register study (2011)

Direct costs of stroke patients can be continuously monitored on a national level. PERFECT Stroke database in Finland. (2011)

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial (2011)

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (2011)

Association of Early National Institutes of Health Stroke Scale Improvement with Vessel Recanalization and Functional outcome After intravenous thrombolysis in ischaemic stroke (2011)

Angiotensin receptor blockers for acute stroke: Results of the Scandinavian Candesartan Acute Stroke Trial (SCAST), a randomized, and placebo-controlled trial (2011)

Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR (2010)

Angiotensin receptor blockade in acute stroke.The Scandinavian Candesartan Acute Stroke Trial. Rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003) (2010)